| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027474910 |
| P356 | DOI | 10.1186/1475-2875-12-394 |
| P932 | PMC publication ID | 3831258 |
| P698 | PubMed publication ID | 24191920 |
| P5875 | ResearchGate publication ID | 258312853 |
| P50 | author | Thomas L. Richie | Q37382432 |
| P2093 | author name string | Xiaoyan Zou | |
| Vincent R Gerbasi | |||
| Brent L House | |||
| Michael D Zyzak | |||
| P2860 | cites work | Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here? | Q37595803 |
| Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry | Q38261775 | ||
| Biology and immunology of sporozoite invasion of liver cells and exoerythrocytic development of malaria parasites | Q39515341 | ||
| Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. | Q42804642 | ||
| Primary sequences of two small subunit ribosomal RNA genes from Plasmodium falciparum | Q43435994 | ||
| Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. | Q44146651 | ||
| Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes | Q44161605 | ||
| Complete development of hepatic stages of Plasmodium falciparum in vitro | Q44487027 | ||
| A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults | Q47835936 | ||
| Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. | Q47879434 | ||
| Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. | Q47992617 | ||
| Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. | Q50773884 | ||
| Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging | Q27335248 | ||
| Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites | Q28212476 | ||
| Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies | Q34255253 | ||
| T cells as mediators of protective immunity against liver stages of Plasmodium | Q35066264 | ||
| Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites | Q36668566 | ||
| Malaria vaccines: are we getting closer? | Q36748243 | ||
| Plasmodium falciparum malaria vaccines in development | Q37103927 | ||
| Plasmodium pre-erythrocytic stages: what's new? | Q37301943 | ||
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 394 | |
| P577 | publication date | 2013-11-05 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparum | |
| P478 | volume | 12 |
| Q54216698 | A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. |
| Q40438040 | An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites |
| Q38794455 | An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials. |
| Q35231780 | Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells |
| Q52655657 | Humanized DRAGA mice immunized with Plasmodium falciparum sporozoites and chloroquine elicit protective pre-erythrocytic immunity. |
| Q34340419 | Humanized HLA-DR4.RagKO.IL2RγcKO.NOD (DRAG) mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria |
| Q92475802 | Identification of Plasmodium falciparum proteoforms from liver stage models |
| Q60948814 | Kupffer Cells Survive Sporozoite Exposure and Respond with a Rapid Cytokine Release |
| Q26781372 | Malaria vaccines: identifying Plasmodium falciparum liver-stage targets |
| Q36211878 | Molecular Markers of Radiation Induced Attenuation in Intrahepatic Plasmodium falciparum Parasites |
| Q38260909 | New insight-guided approaches to detect, cure, prevent and eliminate malaria |
| Q92976912 | Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform |
| Q35917180 | Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice |
| Q92449403 | Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ) |
| Q64947790 | Vaccination With Sporozoites: Models and Correlates of Protection. |
Search more.